Sponsor or institution

Clinical trials and research at University of Ulm

• 27Clinical trials
• 21Countries

Newest trials

All recruiting trials (27)

• Glucose levels during a 6 km loaded march

  We will test how blood sugar changes during a 6 km march carrying 15 kg of equipment in healthy soldiers using continuous glucose monitors.

  Recruiting University of Ulm · Ulm · NCT07543705

• Parental metabolism's imprint on the fetal epigenome in gestational diabetes

  We will see if parents' metabolism during pregnancy is linked to epigenetic changes in the fetus in pregnancies with and without gestational diabetes.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07436195

• How changing thyroid hormone levels affects blood sugar, lipids, and energy use

  This trial will test whether raising or lowering thyroid hormones in people with newly diagnosed Graves' disease or thyroid cancer changes blood sugar, insulin, and lipid metabolism using oral glucose tolerance tests.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07410637

• Once-weekly semaglutide for weight loss in adolescents with monogenic obesity

  This study tests whether once-weekly semaglutide 2.4 mg together with a reduced-calorie diet and increased activity helps adolescents with monogenic obesity lose weight, reduce hunger, and improve quality of life over 68 weeks.

  Recruiting University of Ulm · Paris and 6 other locations · NCT07302802

• Global registry for genetic obesity

  This registry collects health and genetic information from people with genetically confirmed or early-onset severe obesity to see if different genes relate to symptoms, complications, and treatment responses.

  Recruiting University of Ulm · Ulm · NCT07296900

• Immunoadsorption treatment for chronic inflammatory demyelinating polyneuropathy

  This observational study will try immunoadsorption as a next-step treatment for adults with CIDP who do not respond well to IVIg or methylprednisolone.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT07154524

• Investigating how brain signals affect organ function in health and disease

  This study tests how blocking brain signals with atropine during a glucose test affects organ function in healthy people and those at risk for metabolic disorders, while also looking at differences between men and women.

  Recruiting University of Ulm · Ulm · NCT06912048

• Using advanced imaging to assess inflammation in bowel diseases

  This study is testing if a new imaging technique can help doctors better see inflammation in patients with Inflammatory Bowel Disease compared to the standard method.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT06892990

• High-calorie nutrition for ALS patients with PEG feeding

  This study is testing if a high-calorie diet can help ALS patients who are fed through a tube maintain their weight and live longer.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT06877143

• Using MRI to study brain differences in metabolic diseases

  This study is trying to see how brain differences in people with metabolic diseases compare to healthy individuals using MRI scans.

  Recruiting University of Ulm · Ulm · NCT06709846

• Protecting fertility in young cancer patients

  This study is trying to find ways to help young cancer patients keep their ability to have children after treatment by looking at what might affect their fertility.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT06692868

• Comparing Trastuzumab-Deruxtecan to standard therapy for early breast cancer patients with molecular relapse

  This study is testing if a new treatment called Trastuzumab-Deruxtecan can help early breast cancer patients with a relapse feel better compared to standard therapy options.

  Recruiting Phase 3 University of Ulm · Ulm · NCT06643585

• Cooling treatment to prevent nerve damage from chemotherapy

  This study is testing if a cooling treatment for the hands and feet can help women undergoing chemotherapy for breast and gynecological cancers avoid nerve damage.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT06627348

• Comparing standard and intensive surveillance for early breast cancer patients

  This study is trying to see if more frequent check-ups and tests can help early breast cancer patients live longer compared to regular check-ups.

  Recruiting University of Ulm · Ulm · NCT05658172

• Combining Abemaciclib with Endocrine Therapy for Advanced Breast Cancer

  This study is testing if combining a drug called Abemaciclib with other hormone treatments can help women with advanced breast cancer feel better and manage side effects more effectively.

  Recruiting at 54 sites Phase 4 University of Ulm · Aalen and 53 other locations · NCT05362760

• Using exosomes to modulate the immune response in critically ill COVID-19 patients

  This study is testing whether exosomes from stem cells can help improve the immune response and reduce inflammation in critically ill COVID-19 patients.

  Recruiting University of Ulm · Ulm · NCT05191381

• Combining Venetoclax and Rituximab for treating Waldenström's Macroglobulinemia

  This study is testing whether combining two medications, Venetoclax and Rituximab, can provide a better treatment option for older patients with Waldenström's Macroglobulinemia who haven't had treatment before.

  Recruiting at 12 sites Phase 2 University of Ulm · Bielefeld and 13 other locations · NCT05099471

• Comparing immunoadsorption and immunoglobulins for treating CIDP

  This study is testing whether a new treatment called immunoadsorption works better than immunoglobulin for people with CIDP who haven't improved with other medications.

  Recruiting Phase 2 University of Ulm · Ulm, Baden-Wurttemberg · NCT04881682

• Comparing immunoadsorption and plasma exchange for treating Guillain-Barré Syndrome

  This study is testing whether immunoadsorption works better than plasma exchange for treating adults with Guillain-Barré Syndrome.

  Recruiting University of Ulm · Ulm, Baden-Wurttemberg · NCT04871035

• Venetoclax with intensive induction and consolidation chemotherapy for newly diagnosed AML and MDS‑EB‑2

  This trial tests whether adding venetoclax to standard intensive induction and consolidation chemotherapy helps adults (18–75) with newly diagnosed acute myeloid leukemia or MDS‑EB‑2.

  Recruiting at 76 sites Phase 3 University of Ulm · Innsbruck and 90 other locations · NCT04628026

• Registry for patients with pancreatic ductal adenocarcinoma

  This study is collecting information from people newly diagnosed with pancreatic cancer to help improve understanding and treatment of the disease.

  Recruiting University of Ulm · Ulm · NCT04099134

• Registry for patients with lipodystrophy

  This study is creating a registry to track the health and progress of people with lipodystrophy so that researchers can better understand the condition and improve care.

  Recruiting at 28 sites University of Ulm · Vienna and 27 other locations · NCT03553420

• Registry for patients with BCR-ABL1-negative myeloid neoplasms

  This study is collecting information and samples from patients with a specific type of blood cancer to better understand the disease and how it affects their lives.

  Recruiting at 27 sites University of Ulm · Augsburg and 29 other locations · NCT03125707

• Examining Monocyte Profiles in Critically Ill Patients with Pseudomonas Aeruginosa Sepsis

  This study is trying to see if the type of immune cells in the blood of critically ill patients with sepsis from Pseudomonas aeruginosa can tell us more about how sick they are and how they might recover.

  Recruiting University of Ulm · Ulm · NCT03044223

• Registry of patients with low grade gliomas

  This study is collecting information from patients with low grade gliomas to see how the disease behaves and what factors might affect treatment and outcomes.

  Recruiting University of Ulm · Ulm · NCT02686229

• Investigating hemophagocytosis in critically ill adults

  This study is trying to see if critically ill adults with low blood cell counts and signs of a serious condition called hemophagocytic lymphohistiocytosis respond to a specific treatment to help improve their situation.

  Recruiting at 2 sites University of Ulm · Ulm and 1 other locations · NCT01913938

• Registry of patient characteristics and outcomes in acute myeloid leukemia

  This study is gathering information from adults with newly diagnosed or returning acute myeloid leukemia to see how different factors affect their treatment and survival over time.

  Recruiting at 86 sites University of Ulm · Graz and 93 other locations · NCT01252485

Quick answers

How many clinical trials run by University of Ulm are recruiting right now?

27, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 21 countries. The most sites are in Germany (27 trials), Netherlands (3 trials), Austria (3 trials), France (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →